Sonoma Pharmaceuticals (SNOA) Other Working Capital Changes (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Other Working Capital Changes of -$1.0 million for Q1 2026, down 2858.82% year-over-year from $36464.8 in Q1 2025, and down 290.53% quarter-over-quarter from $528000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$1.0 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 2858.82% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$452000.0 (down 159.77% YoY), while the FY2026 annual figure was -$452000.0, down 159.77% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.0 million, down from $528000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $448000.0 in Q2 2025, with the low at -$79000.0 in Q1 2023.
- The 5-year median for Other Working Capital Changes is -$42500.0 (2024), against an average of -$4250.0.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes soared 1489.47% in 2025, then tumbled 2858.82% in 2026.
- Sonoma Pharmaceuticals' Other Working Capital Changes stood at -$1.2 million in 2022, then surged by 94.24% to -$68000.0 in 2023, then jumped by 44.12% to -$38000.0 in 2024, then jumped by 1489.47% to $528000.0 in 2025, then slumped by 290.53% to -$1.0 million in 2026.
- Business Quant data shows SNOA's Other Working Capital Changes at -$1.0 million in Q1 2026, $528000.0 in Q4 2025, and -$422000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40,000.00 |
| Jun 30, 2026 | -40,000.00 |
| Jun 30, 2026 | -40,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Mar 31, 2026 | -38,000.00 |
| Dec 31, 2025 | 161,000.00 |
| Dec 31, 2025 | 161,000.00 |
| Dec 31, 2025 | 161,000.00 |
| Sep 30, 2025 | -56,000.00 |
| Sep 30, 2025 | -56,000.00 |
| Sep 30, 2025 | -56,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Dec 31, 2024 | -34,000.00 |
| Dec 31, 2024 | -34,000.00 |